SERPINB5 expression: Association with CCRT response and prognostic value in rectal cancer

I. Wei Chang, Kai Wen Liu, Marlon Ragunanan, Hong Lin He, Yow Ling Shiue, Shou Chun Yu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Due to the varying characteristics and conflicting outcomes on the overall survival of rectal cancer patients, many studies have been undertaken to determine various prognostic and predictive factors for the mainstay treatment of CCRT followed by surgery. Cancer cell motility contributes to tumor invasion, migration and eventually metastasis. However, the genes associated with cell motility (i.e., GO:0048870) have not been systemically evaluated in rectal cancers. Methods: A comparative analysis of gene expression profiles was applied to the transcriptomic dataset (GSE35452) with a focus on genes associated with cell motility (GO:0048870), where SERPINB5 was recognized as the most significantly up-regulated gene. Tumor samples from 172 primary rectal cancer patients who underwent neoadjuvant CCRT followed by surgical resection were collected. Immunohistochemistry was used to semi-quantitatively assess the expression level of SERPINB5 protein. Statistical analyses of SERPINB5 expression and various clinicopathological features as well as survival were then performed. Results: High immunoreactivity of SERPINB5 was significantly linked to pre- and post-CCRT advanced disease, lymphovascular invasion, and poor response to CCRT (all P ≤ 0.015). SERPINB5 overexpression was not only negatively associated with disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) rates in univariate analyses but also was an independent prognostic factor for DSS and MeFS in rectal cancer patients (all P ≤ 0.043). Conclusion: SERPINB5 may play an important role in rectal cancer progression and response to neoadjuvant CCRT and serve as a novel prognostic factor.

Original languageEnglish
Pages (from-to)376-384
Number of pages9
JournalInternational Journal of Medical Sciences
Volume15
Issue number4
DOIs
Publication statusPublished - Feb 12 2018

Fingerprint

Rectal Neoplasms
Survival
Cell Movement
Neoplasm Metastasis
Genes
Neoplasms
Transcriptome
Survival Rate
Immunohistochemistry
Recurrence

Keywords

  • CCRT
  • Chemoradiotherapy
  • Maspin
  • Rectal cancer
  • SERPINB5

ASJC Scopus subject areas

  • Medicine(all)

Cite this

SERPINB5 expression : Association with CCRT response and prognostic value in rectal cancer. / Chang, I. Wei; Liu, Kai Wen; Ragunanan, Marlon; He, Hong Lin; Shiue, Yow Ling; Yu, Shou Chun.

In: International Journal of Medical Sciences, Vol. 15, No. 4, 12.02.2018, p. 376-384.

Research output: Contribution to journalArticle

Chang, I. Wei ; Liu, Kai Wen ; Ragunanan, Marlon ; He, Hong Lin ; Shiue, Yow Ling ; Yu, Shou Chun. / SERPINB5 expression : Association with CCRT response and prognostic value in rectal cancer. In: International Journal of Medical Sciences. 2018 ; Vol. 15, No. 4. pp. 376-384.
@article{781a0645974e476f95d2b1fec982d55f,
title = "SERPINB5 expression: Association with CCRT response and prognostic value in rectal cancer",
abstract = "Background: Due to the varying characteristics and conflicting outcomes on the overall survival of rectal cancer patients, many studies have been undertaken to determine various prognostic and predictive factors for the mainstay treatment of CCRT followed by surgery. Cancer cell motility contributes to tumor invasion, migration and eventually metastasis. However, the genes associated with cell motility (i.e., GO:0048870) have not been systemically evaluated in rectal cancers. Methods: A comparative analysis of gene expression profiles was applied to the transcriptomic dataset (GSE35452) with a focus on genes associated with cell motility (GO:0048870), where SERPINB5 was recognized as the most significantly up-regulated gene. Tumor samples from 172 primary rectal cancer patients who underwent neoadjuvant CCRT followed by surgical resection were collected. Immunohistochemistry was used to semi-quantitatively assess the expression level of SERPINB5 protein. Statistical analyses of SERPINB5 expression and various clinicopathological features as well as survival were then performed. Results: High immunoreactivity of SERPINB5 was significantly linked to pre- and post-CCRT advanced disease, lymphovascular invasion, and poor response to CCRT (all P ≤ 0.015). SERPINB5 overexpression was not only negatively associated with disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) rates in univariate analyses but also was an independent prognostic factor for DSS and MeFS in rectal cancer patients (all P ≤ 0.043). Conclusion: SERPINB5 may play an important role in rectal cancer progression and response to neoadjuvant CCRT and serve as a novel prognostic factor.",
keywords = "CCRT, Chemoradiotherapy, Maspin, Rectal cancer, SERPINB5",
author = "Chang, {I. Wei} and Liu, {Kai Wen} and Marlon Ragunanan and He, {Hong Lin} and Shiue, {Yow Ling} and Yu, {Shou Chun}",
year = "2018",
month = "2",
day = "12",
doi = "10.7150/ijms.22823",
language = "English",
volume = "15",
pages = "376--384",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "4",

}

TY - JOUR

T1 - SERPINB5 expression

T2 - Association with CCRT response and prognostic value in rectal cancer

AU - Chang, I. Wei

AU - Liu, Kai Wen

AU - Ragunanan, Marlon

AU - He, Hong Lin

AU - Shiue, Yow Ling

AU - Yu, Shou Chun

PY - 2018/2/12

Y1 - 2018/2/12

N2 - Background: Due to the varying characteristics and conflicting outcomes on the overall survival of rectal cancer patients, many studies have been undertaken to determine various prognostic and predictive factors for the mainstay treatment of CCRT followed by surgery. Cancer cell motility contributes to tumor invasion, migration and eventually metastasis. However, the genes associated with cell motility (i.e., GO:0048870) have not been systemically evaluated in rectal cancers. Methods: A comparative analysis of gene expression profiles was applied to the transcriptomic dataset (GSE35452) with a focus on genes associated with cell motility (GO:0048870), where SERPINB5 was recognized as the most significantly up-regulated gene. Tumor samples from 172 primary rectal cancer patients who underwent neoadjuvant CCRT followed by surgical resection were collected. Immunohistochemistry was used to semi-quantitatively assess the expression level of SERPINB5 protein. Statistical analyses of SERPINB5 expression and various clinicopathological features as well as survival were then performed. Results: High immunoreactivity of SERPINB5 was significantly linked to pre- and post-CCRT advanced disease, lymphovascular invasion, and poor response to CCRT (all P ≤ 0.015). SERPINB5 overexpression was not only negatively associated with disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) rates in univariate analyses but also was an independent prognostic factor for DSS and MeFS in rectal cancer patients (all P ≤ 0.043). Conclusion: SERPINB5 may play an important role in rectal cancer progression and response to neoadjuvant CCRT and serve as a novel prognostic factor.

AB - Background: Due to the varying characteristics and conflicting outcomes on the overall survival of rectal cancer patients, many studies have been undertaken to determine various prognostic and predictive factors for the mainstay treatment of CCRT followed by surgery. Cancer cell motility contributes to tumor invasion, migration and eventually metastasis. However, the genes associated with cell motility (i.e., GO:0048870) have not been systemically evaluated in rectal cancers. Methods: A comparative analysis of gene expression profiles was applied to the transcriptomic dataset (GSE35452) with a focus on genes associated with cell motility (GO:0048870), where SERPINB5 was recognized as the most significantly up-regulated gene. Tumor samples from 172 primary rectal cancer patients who underwent neoadjuvant CCRT followed by surgical resection were collected. Immunohistochemistry was used to semi-quantitatively assess the expression level of SERPINB5 protein. Statistical analyses of SERPINB5 expression and various clinicopathological features as well as survival were then performed. Results: High immunoreactivity of SERPINB5 was significantly linked to pre- and post-CCRT advanced disease, lymphovascular invasion, and poor response to CCRT (all P ≤ 0.015). SERPINB5 overexpression was not only negatively associated with disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) rates in univariate analyses but also was an independent prognostic factor for DSS and MeFS in rectal cancer patients (all P ≤ 0.043). Conclusion: SERPINB5 may play an important role in rectal cancer progression and response to neoadjuvant CCRT and serve as a novel prognostic factor.

KW - CCRT

KW - Chemoradiotherapy

KW - Maspin

KW - Rectal cancer

KW - SERPINB5

UR - http://www.scopus.com/inward/record.url?scp=85045218574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045218574&partnerID=8YFLogxK

U2 - 10.7150/ijms.22823

DO - 10.7150/ijms.22823

M3 - Article

C2 - 29511373

AN - SCOPUS:85045218574

VL - 15

SP - 376

EP - 384

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 4

ER -